# An Investigational Scan (Flotufolastat F 18 PET/CT) for Detecting Residual or Recurrent Disease in Patients Who Completed Focal Therapy for Prostate Cancer.

> **NCT07185165** · PHASE2 · RECRUITING · sponsor: **Jonsson Comprehensive Cancer Center** · enrollment: 81 (estimated)

## Conditions studied

- Prostate Carcinoma

## Interventions

- **PROCEDURE:** Computed Tomography
- **DRUG:** Fluorine F 18 Flotufolastat
- **PROCEDURE:** Positron Emission Tomography
- **PROCEDURE:** Ultrasound-Guided Prostate Biopsy

## Key facts

- **NCT ID:** NCT07185165
- **Lead sponsor:** Jonsson Comprehensive Cancer Center
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-10-09
- **Primary completion:** 2035-10-25
- **Final completion:** 2036-10-25
- **Target enrollment:** 81 (ESTIMATED)
- **Last updated:** 2025-11-10

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07185165

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07185165, "An Investigational Scan (Flotufolastat F 18 PET/CT) for Detecting Residual or Recurrent Disease in Patients Who Completed Focal Therapy for Prostate Cancer.". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT07185165. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*